Nystatin Oral Suspension, USP, 500,000 units/5 mL, For Institutional Use Only, packaged in 5 mL cups, Rx Only, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-4810-05
Published June 13, 2018 · Recall initiated: May 29, 2018
Summary
FDA records drug Class III recall D-0865-2018, published June 13, 2018 and initiated May 29, 2018. Recalling firm: Pharmaceutical Associates Inc; Status: Terminated; Reported quantity: 275400 cups; Lot: Lot: B5B8 Exp. 07/2019. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Resuspension problems: Out of specification for appearance and resuspendability.
What to do
Voluntary: Firm initiated · Letter
Get an email if NYSTATIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- NYSTATIN
- Manufacturer
- Pharmaceutical Associates Inc
- Distributor
- Nationwide
- UPC
- 0301210810022
- Lot
- Lot: B5B8 Exp. 07/2019
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANystatin Cream USP, (100,000 USP Nystatin Units), NET WT 15 g, Rx only, 15 g tube, Manufactured by Padagis,July 22, 2026
- FDANystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, Rx ONLY, packaged in a) 16 fl ozAugust 18, 2021
- FDANystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl. oz. (473 mL), Rx only,August 19, 2020
- FDANystatin Oral Suspension, USP, 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl oz (473 mL) bottle, RxApril 1, 2020
- FDAValsartan Tablets USP, 320 mg, 90 tablet, Rx Only, Manufactured by: Jubilant Generics Ltd. Roorkee - 247661,June 13, 2018
- FDAnordicBrainEX Product Usage: nordicBrainEx is an image processing software package to be used by trainedJune 6, 2018
Questions about this recall
Was Nystatin Oral Suspension, USP, 500,000 units/5 mL, For Institutional Use Only, packaged in 5 mL cups, Rx Only, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-4810-05 recalled?
Yes. FDA published recall D-0865-2018 on June 13, 2018. Reported hazard: Resuspension problems: Out of specification for appearance and resuspendability.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: NYSTATIN. UPC: 0301210810022.